Patents by Inventor Peter Andreas Loschmann

Peter Andreas Loschmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinoxaline-carboxylic acid derivatives
    Patent number: 6288065
    Abstract: The disclosure relates to quinoxaline derivates of Formula I wherein R1, R4, R5, R6, R7 and R8 are defined in the disclosure, as well as their production and use in medicinal agents.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: September 11, 2001
    Assignee: Schering Aktiengeseellschaft
    Inventors: Andreas Huth, Ralph Schmiechen, Ilse Beetz, Ingrid Schumann, Lechoslaw Turski, Peter Andreas Loschmann, David Norman Stephens, Dieter Seidelmann, Martin Kruger, Dieter Rahtz, Peter Holscher
  • Use of quisqualate receptor antagonists
    Patent number: 6191132
    Abstract: The new use of antagonists of the AMPA receptor complex and its physiologically compatible salts as pharmaceutical agents for prevention and treatment of Parkinson's disease as well as pharmaceutical agents, which contain these compounds, is described.
    Type: Grant
    Filed: November 4, 1993
    Date of Patent: February 20, 2001
    Assignee: Schering Aktiengesellschaft
    Inventors: Thomas Klockgether, Peter-Andreas Löschmann, David Norman Stephens, Lechoslaw Turski, Helmut Wachtel
  • Combined treatment of multiple sclerosis
    Patent number: 6060501
    Abstract: A pharmaceutically composition for treating MS comprising an effective amount of a combination of a PDE IV inhibitor and an anti-inflammatory and immunomodulatory drug in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: May 9, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Helmut Wachtel, Peter-Andreas Loschmann, Hermann Graf, H. Daniel Perez
  • Quinoxaline-phosphonic acid derivatives
    Patent number: 6057304
    Abstract: The disclosure relates to quinoxaline derivatives of Formula I ##STR1## wherein R.sup.1, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are as defined in the disclosure, as well as their production and use in medicinal agents.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: May 2, 2000
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Huth, Ralph Schmiechen, Ilse Beetz, Ingrid Schumann, Lechoslaw Turski, Peter Andreas Loschmann, David Norman Stephens, Dieter Seidelmann, Martin Kruger, Dieter Rahtz, Peter Holscher
  • N-(8.alpha.-ergolinyl)-amides
    Patent number: 5547958
    Abstract: 8.alpha.-acylamino ergolines are useful dopamine agonists.
    Type: Grant
    Filed: December 27, 1994
    Date of Patent: August 20, 1996
    Assignee: Schering Aktiengesellschaft
    Inventors: Gerhard Sauer, Thomas Brumby, Helmut Wachtel, Jonathan Turner, Peter-Andreas Loschmann
  • 8.alpha.-acylamino ergolines and use as pharmaceutical agents
    Patent number: 5212178
    Abstract: 8.alpha.-acylamino ergolines are useful dopamine agonists.
    Type: Grant
    Filed: May 14, 1990
    Date of Patent: May 18, 1993
    Assignee: Schering Aktiengesellschaft
    Inventors: Gerhard Sauer, Thomas Brumby, Helmut Wachtel, Jonathan Turner, Peter-Andreas Loschmann
  • Agent for treatment of Parkinson's disease
    Patent number: 4970200
    Abstract: The enzyme cofactor nicotinamide adenine dinucleotide or a salt thereof is useful for the treatment of Parkinson's disease.
    Type: Grant
    Filed: March 1, 1989
    Date of Patent: November 13, 1990
    Assignee: Schering Aktiengesellschaft
    Inventors: Walther Birkmayer, Jorg Birkmayer, Reinhard Horowski, Helmut Wachtel, Peter-Andreas Loschmann
  • I*-diagnostics for monoamine receptors using ergolines
    Patent number: 4857298
    Abstract: Compounds of general Formula I labeled with .sup.121 I, .sup.122 I, .sup.123 I, .sup.124 I, .sup.125 I, .sup.131 I and .sup.132 I isotopes ##STR1## wherein R.sup.6 is a C.sub.1-6 aliphatic hydrocarbon residue andC.sub.2 -C.sub.3 C.sub.9 -C.sub.10 is a single or a double bond, as well as their acid addition salts,are useful as diagnostic media, e.g., in imaging dopamine and other receptors.
    Type: Grant
    Filed: July 10, 1987
    Date of Patent: August 15, 1989
    Assignee: Schering Aktiengesellschaft
    Inventors: Helmut Wachtel, Herbert H. Schneider, Peter-Andreas Loschmann, Rainer Dorow, Reinhard Horowski, Bernard Acksteiner, Paul-Eberhard Schulze, Gerhard Sauer